NCT01289067 2018-02-13
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
Clinical Trials
4 trialsNCT00370383 2012-08-07
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Agennix
Phase 2 Completed
NCT00268970 2012-04-30
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Agennix
Phase 2 Completed
NCT00265655 2012-03-28
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Agennix
Phase 2 Completed